Coagulation Sciences

Coagulation Sciences is a private U.S. medical device and diagnostics company developing point-of-care coagulation testing technology for transfusion management. Its lead product, the Multiple Coagulation Test System (MCTS), is a desktop device intended to rapidly analyze coagulation disorders at the bedside and compare multiple blood, factor, and drug therapies to guide individualized treatment. The company positions its technology as a personalized medicine approach for patients with major bleeding, especially in operating-room settings such as cardiac surgery. Coagulation Sciences aims to reduce unnecessary transfusions, improve patient safety, and lower healthcare costs for hospitals and blood banks. The business appears focused on commercialization of its proprietary transfusion-management testing platform rather than a therapeutic drug pipeline.